Inno Laser Technology Co., Ltd.

SZSE:301021 Rapport sur les actions

Capitalisation boursière : CN¥3.5b

Inno Laser Technology Bilan de santé

Santé financière contrôle des critères 4/6

Inno Laser Technology has a total shareholder equity of CN¥976.7M and total debt of CN¥13.0M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥1.2B and CN¥224.2M respectively.

Informations clés

1.3%

Ratio d'endettement

CN¥13.00m

Dette

Ratio de couverture des intérêtsn/a
Argent liquideCN¥321.76m
Fonds propresCN¥976.69m
Total du passifCN¥224.24m
Total des actifsCN¥1.20b

Mises à jour récentes de la santé financière

Recent updates

Inno Laser Technology Co., Ltd.'s (SZSE:301021) 39% Share Price Surge Not Quite Adding Up

Oct 14
Inno Laser Technology Co., Ltd.'s (SZSE:301021) 39% Share Price Surge Not Quite Adding Up

Inno Laser Technology (SZSE:301021) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Oct 08
Inno Laser Technology (SZSE:301021) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Inno Laser Technology Co., Ltd.'s (SZSE:301021) 34% Price Boost Is Out Of Tune With Revenues

Jul 23
Inno Laser Technology Co., Ltd.'s (SZSE:301021) 34% Price Boost Is Out Of Tune With Revenues

Optimistic Investors Push Inno Laser Technology Co., Ltd. (SZSE:301021) Shares Up 31% But Growth Is Lacking

Mar 06
Optimistic Investors Push Inno Laser Technology Co., Ltd. (SZSE:301021) Shares Up 31% But Growth Is Lacking

Analyse de la situation financière

Passif à court terme: 301021's short term assets (CN¥833.7M) exceed its short term liabilities (CN¥200.3M).

Passif à long terme: 301021's short term assets (CN¥833.7M) exceed its long term liabilities (CN¥23.9M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 301021 has more cash than its total debt.

Réduire la dette: 301021's debt to equity ratio has reduced from 18.3% to 1.3% over the past 5 years.

Couverture de la dette: 301021's operating cash flow is negative, therefore debt is not well covered.

Couverture des intérêts: Insufficient data to determine if 301021's interest payments on its debt are well covered by EBIT.


Bilan


Découvrir des entreprises saines